Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Corbion, formerly known as Purac, is a global market leader in lactic acid and its derivatives, and a leading supplier of resorbable polymers for the pharmaceutical and medical device industries. The company's biomedical division specializes in high-quality, bio-based polymers such as PLA, PLGA, and PCL, which are used as excipients for controlled-release drug delivery and as scaffolds for tissue engineering. Purac America serves as the North American hub for these operations, providing critical raw materials and contract manufacturing services for biodegradable medical implants and long-acting injectables. Their products are integral to the development of advanced therapeutic delivery systems and orthopedic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purac America.